Júlia Zocca Nunes de Barros, Luma Eduarda Lopes Escalante, Maria João Matos, Edson Luis Maistro
{"title":"6,7-二羟基-3-(2-硝基苯基)香豆素在人体细胞中的生物安全性评价。","authors":"Júlia Zocca Nunes de Barros, Luma Eduarda Lopes Escalante, Maria João Matos, Edson Luis Maistro","doi":"10.1002/jat.4880","DOIUrl":null,"url":null,"abstract":"<p><p>Coumarins are considered a privileged scaffold in medicinal chemistry, as they may interact with biological macromolecules, presenting several pharmacological properties. Their potential makes them an object of study for the evaluation of their safety for humans, which is essential in the design of a potential drug. 6,7-Dihydroxy-3-(2-nitrophenyl)coumarin is a synthetic derivative with antioxidant properties, amongst other biological activities under study. The main goal of this study is to evaluate the potential cytotoxic and genotoxic effects of this molecule in peripheral blood mononuclear cells (PBMCs) and human hepatocellular carcinoma cells (HepG2/C3A). The results obtained for the cytotoxicity assays, evaluated by the resazurin assay, using concentrations between 0.1 and 50 μg/mL, showed that there is no decrease in cell viability for both cell lines. Regarding genotoxic assays, the data obtained by the comet assay and the micronucleus test, up to a concentration of 30 μg/mL, did not show significant DNA damage and/or chromosomal mutations for both cell types. Given these results, it can be concluded that 6,7-dihydroxy-3-(2-nitrophenyl)coumarin, up to a concentration of 30 μg/mL, does not present cytotoxic or genotoxic effects in human cells with and without hepatic metabolism. Considering that this family of coumarins, in general, presents their biological effect at low concentrations (mainly nanomolar range), the results obtained here encourage further studies with this molecule in drug discovery programs. 6,7-Dihydroxy-3-(2-nitrophenyl)coumarin is a new synthetic derivative with antioxidant properties, amongst other biological activities under study. The main goal of this study was to evaluate the potential cytotoxicity and genotoxicity of this molecule in human cells in vitro. Cytotoxicity assays in concentrations between 0.1 and 50 μg/mL showed no decrease in cell viability. Comet assay and the micronucleus test, up to a concentration of 30 μg/mL, did not show genetic toxicity.</p>","PeriodicalId":15242,"journal":{"name":"Journal of Applied Toxicology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biosafety Evaluation of 6,7-Dihydroxy-3-(2-Nitrophenyl)Coumarin in Human Cells.\",\"authors\":\"Júlia Zocca Nunes de Barros, Luma Eduarda Lopes Escalante, Maria João Matos, Edson Luis Maistro\",\"doi\":\"10.1002/jat.4880\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Coumarins are considered a privileged scaffold in medicinal chemistry, as they may interact with biological macromolecules, presenting several pharmacological properties. Their potential makes them an object of study for the evaluation of their safety for humans, which is essential in the design of a potential drug. 6,7-Dihydroxy-3-(2-nitrophenyl)coumarin is a synthetic derivative with antioxidant properties, amongst other biological activities under study. The main goal of this study is to evaluate the potential cytotoxic and genotoxic effects of this molecule in peripheral blood mononuclear cells (PBMCs) and human hepatocellular carcinoma cells (HepG2/C3A). The results obtained for the cytotoxicity assays, evaluated by the resazurin assay, using concentrations between 0.1 and 50 μg/mL, showed that there is no decrease in cell viability for both cell lines. Regarding genotoxic assays, the data obtained by the comet assay and the micronucleus test, up to a concentration of 30 μg/mL, did not show significant DNA damage and/or chromosomal mutations for both cell types. Given these results, it can be concluded that 6,7-dihydroxy-3-(2-nitrophenyl)coumarin, up to a concentration of 30 μg/mL, does not present cytotoxic or genotoxic effects in human cells with and without hepatic metabolism. Considering that this family of coumarins, in general, presents their biological effect at low concentrations (mainly nanomolar range), the results obtained here encourage further studies with this molecule in drug discovery programs. 6,7-Dihydroxy-3-(2-nitrophenyl)coumarin is a new synthetic derivative with antioxidant properties, amongst other biological activities under study. The main goal of this study was to evaluate the potential cytotoxicity and genotoxicity of this molecule in human cells in vitro. Cytotoxicity assays in concentrations between 0.1 and 50 μg/mL showed no decrease in cell viability. Comet assay and the micronucleus test, up to a concentration of 30 μg/mL, did not show genetic toxicity.</p>\",\"PeriodicalId\":15242,\"journal\":{\"name\":\"Journal of Applied Toxicology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Applied Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jat.4880\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"TOXICOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Applied Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jat.4880","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"TOXICOLOGY","Score":null,"Total":0}
Biosafety Evaluation of 6,7-Dihydroxy-3-(2-Nitrophenyl)Coumarin in Human Cells.
Coumarins are considered a privileged scaffold in medicinal chemistry, as they may interact with biological macromolecules, presenting several pharmacological properties. Their potential makes them an object of study for the evaluation of their safety for humans, which is essential in the design of a potential drug. 6,7-Dihydroxy-3-(2-nitrophenyl)coumarin is a synthetic derivative with antioxidant properties, amongst other biological activities under study. The main goal of this study is to evaluate the potential cytotoxic and genotoxic effects of this molecule in peripheral blood mononuclear cells (PBMCs) and human hepatocellular carcinoma cells (HepG2/C3A). The results obtained for the cytotoxicity assays, evaluated by the resazurin assay, using concentrations between 0.1 and 50 μg/mL, showed that there is no decrease in cell viability for both cell lines. Regarding genotoxic assays, the data obtained by the comet assay and the micronucleus test, up to a concentration of 30 μg/mL, did not show significant DNA damage and/or chromosomal mutations for both cell types. Given these results, it can be concluded that 6,7-dihydroxy-3-(2-nitrophenyl)coumarin, up to a concentration of 30 μg/mL, does not present cytotoxic or genotoxic effects in human cells with and without hepatic metabolism. Considering that this family of coumarins, in general, presents their biological effect at low concentrations (mainly nanomolar range), the results obtained here encourage further studies with this molecule in drug discovery programs. 6,7-Dihydroxy-3-(2-nitrophenyl)coumarin is a new synthetic derivative with antioxidant properties, amongst other biological activities under study. The main goal of this study was to evaluate the potential cytotoxicity and genotoxicity of this molecule in human cells in vitro. Cytotoxicity assays in concentrations between 0.1 and 50 μg/mL showed no decrease in cell viability. Comet assay and the micronucleus test, up to a concentration of 30 μg/mL, did not show genetic toxicity.
期刊介绍:
Journal of Applied Toxicology publishes peer-reviewed original reviews and hypothesis-driven research articles on mechanistic, fundamental and applied research relating to the toxicity of drugs and chemicals at the molecular, cellular, tissue, target organ and whole body level in vivo (by all relevant routes of exposure) and in vitro / ex vivo. All aspects of toxicology are covered (including but not limited to nanotoxicology, genomics and proteomics, teratogenesis, carcinogenesis, mutagenesis, reproductive and endocrine toxicology, toxicopathology, target organ toxicity, systems toxicity (eg immunotoxicity), neurobehavioral toxicology, mechanistic studies, biochemical and molecular toxicology, novel biomarkers, pharmacokinetics/PBPK, risk assessment and environmental health studies) and emphasis is given to papers of clear application to human health, and/or advance mechanistic understanding and/or provide significant contributions and impact to their field.